ELEGEN Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
ELEGEN is a San Carlos, California-based biotechnology company focused on accelerating DNA writing. It aims to deliver a suite of technologies that enable rapid, scalable DNA construction with high quality. The goal is to reprogram biology and develop biologic solutions to address major human challenges. Led by founder Dr. Matthew Hill, the company operates as a commercial-stage player in the synthetic biology landscape. In March 2025, ELEGEN announced ENFINIA DNA enhancement, a development intended to speed synthesis of highly complex DNA. The company targets researchers and developers within biotechnology research who need advanced DNA manufacturing capabilities to support gene modulation and related therapeutic workflows.